Works matching DE "MYELODYSPLASTIC syndromes treatment"
Results: 447
Myelodysplastic Syndromes: Where Do We Go From Here?
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 492
- By:
- Publication type:
- Article
Tricking or Treating Myelodysplastic Syndromes.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 488
- By:
- Publication type:
- Article
When to Treat Myelodysplastic Syndromes.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 480
- By:
- Publication type:
- Article
Management of Myelodysplastic Syndromes: Just the Beginning.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 12, p. 1360
- By:
- Publication type:
- Article
Incremental Gains and a Long Road Ahead in MDS.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 12, p. 1352
- By:
- Publication type:
- Article
Management of Myelodysplastic Syndromes: 2008 Update.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 12, p. 1344
- By:
- Publication type:
- Article
The Myelodysplastic Syndromes: Help Is On The Way!
- Published in:
- Oncology (08909091), 2007, v. 21, n. 1, p. 58
- By:
- Publication type:
- Article
Evolving Classification and Management of Myeloplastic Syndrome.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 1, p. 57
- By:
- Publication type:
- Article
Risk-Based Management of Myelodysplastic Syndrome.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 1, p. 43
- By:
- Publication type:
- Article
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS.
- Published in:
- Nature, 2015, v. 523, n. 7559, p. 183, doi. 10.1038/nature14610
- By:
- Publication type:
- Article
The transcription factor Foxm1 is essential for the quiescence and maintenance of hematopoietic stem cells.
- Published in:
- Nature Immunology, 2015, v. 16, n. 8, p. 810, doi. 10.1038/ni.3204
- By:
- Publication type:
- Article
SUGGESTED READING.
- Published in:
- Cancer Investigation, 2004, v. 22, p. 111
- Publication type:
- Article
DECITABINE IN AML AND MDS.
- Published in:
- 2004
- Publication type:
- Abstract
ARSENIC TRIOXIDE (ATO) IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES.
- Published in:
- 2004
- Publication type:
- Abstract
ERYTHROPOIETIC REMITTING ACTIVITY OF THE IMMUNOMODULATORY THALIDOMIDE ANALOG CC5013 (REVIMID™) IN PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS): RESULTS OF A PHASE I/II TRIAL.
- Published in:
- 2004
- Publication type:
- Abstract
DECITABINE THERAPY IN MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOGENOUS LEUKEMIA.
- Published in:
- 2001
- Publication type:
- Abstract
Real-World Study of the Burden of Myelodysplastic Syndromes in Patients and Their Caregivers in Europe and the United States.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 4, p. 753, doi. 10.1007/s40487-024-00303-5
- By:
- Publication type:
- Article
First Cytogenetic Profile of Omani Patients with de novo Myelodysplastic Syndromes: Comparison with data from Asia, Africa, Europe and North and South America.
- Published in:
- Sultan Qaboos University Medical Journal, 2017, v. 17, n. 3, p. 286, doi. 10.18295/squmj.2017.17.03.005
- By:
- Publication type:
- Article
Sinusitis caused by <italic>Exserohilum rostratum</italic> after cord blood transplantation for myelodysplastic syndrome: A case report and literature review.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Myelodysplastic syndrome treated effectively with testosterone enanthate.
- Published in:
- International Journal of Urology, 2011, v. 18, n. 6, p. 469, doi. 10.1111/j.1442-2042.2011.02757.x
- By:
- Publication type:
- Article
Antifungal prophylaxis with anidulafungin to minimize drug interactions with an antiepileptic treatment in a hematopoietic stem cell transplant recipient.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2015, v. 40, n. 5, p. 601, doi. 10.1111/jcpt.12299
- By:
- Publication type:
- Article
Noninvasive Ventilation in Patients With Hematologic Malignancy: A Retrospective Study.
- Published in:
- Journal of Intensive Care Medicine, 2019, v. 34, n. 3, p. 197, doi. 10.1177/0885066617690725
- By:
- Publication type:
- Article
Azacitidine: In Myelodysplastic Syndromes.
- Published in:
- Drugs, 2005, v. 65, n. 13, p. 1781, doi. 10.2165/00003495-200565130-00004
- By:
- Publication type:
- Article
Azacitidine in Myelodysplastic Syndromes: A Viewpoint by Valeria Santini.
- Published in:
- Drugs, 2005, v. 65, n. 13, p. 1790, doi. 10.2165/00003495-200565130-00005
- By:
- Publication type:
- Article
Sharing Best Practices Benefits Patients.
- Published in:
- American Journal of Clinical Pathology, 2014, p. 38
- Publication type:
- Article
Beyond the Niche: Myelodysplastic Syndrome Topobiology in the Laboratory and in the Clinic.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 4, p. 553, doi. 10.3390/ijms17040553
- By:
- Publication type:
- Article
Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 4, p. 440, doi. 10.3390/ijms17040440
- By:
- Publication type:
- Article
Potential Relationship between Inadequate Response to DNA Damage and Development of Myelodysplastic Syndrome.
- Published in:
- International Journal of Molecular Sciences, 2015, v. 16, n. 1, p. 966, doi. 10.3390/ijms16010966
- By:
- Publication type:
- Article
10th anniversary of the Austrian MDS Platform: aims and ongoing projects.
- Published in:
- Wiener Klinische Wochenschrift, 2015, v. 127, n. 1/2, p. 12, doi. 10.1007/s00508-014-0627-0
- By:
- Publication type:
- Article
Myelodysplastic newborns need early prophylaxis.
- Published in:
- Urology Times, 1999, v. 27, n. 4, p. 13
- By:
- Publication type:
- Article
New approach to neurogenic bladder focuses lower.
- Published in:
- Urology Times, 1996, v. 24, n. 2, p. 12
- By:
- Publication type:
- Article
Controversial conclusions on managing myelodysplasia.
- Published in:
- Urology Times, 1995, v. 23, n. 1, p. 16
- By:
- Publication type:
- Article
Reduced potency of cytotoxic T lymphocytes from patients with high-risk myelodysplastic syndromes.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 9, p. 1135, doi. 10.1007/s00262-016-1865-y
- By:
- Publication type:
- Article
Red cell transfusion thresholds in myelodysplastic syndromes: a clinician survey to inform future clinical trials.
- Published in:
- Internal Medicine Journal, 2017, v. 47, n. 6, p. 695, doi. 10.1111/imj.13434
- By:
- Publication type:
- Article
When should iron chelation therapy be considered in patients with myelodysplasia and other bone marrow failure syndromes with iron overload?
- Published in:
- Internal Medicine Journal, 2012, v. 42, n. 4, p. 450, doi. 10.1111/j.1445-5994.2012.02734.x
- By:
- Publication type:
- Article
Myelodysplasia in the Wellington region 2002-2007: disease incidence and treatment patterns.
- Published in:
- Internal Medicine Journal, 2011, v. 41, n. 5, p. 399, doi. 10.1111/j.1445-5994.2011.02443.x
- By:
- Publication type:
- Article
Leukemic mature B‐cell neoplasm observed during the treatment with romiplostim in patient with thrombocytopenia and liver cirrhosis.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Cardiac Tamponade on the Edge.
- Published in:
- Echocardiography, 2015, v. 32, n. 10, p. 1581, doi. 10.1111/echo.12977
- By:
- Publication type:
- Article
Necessary stem cell transplantation using myeloablative therapy for myelodysplastic syndrome with progression of genotypic abnormalities and TP53 dysfunction in a young adult.
- Published in:
- Pediatric Transplantation, 2014, v. 18, n. 7, p. E255, doi. 10.1111/petr.12334
- By:
- Publication type:
- Article
Romiplostim dose-response in patients with myelodysplastic syndromes.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 6, p. 1445, doi. 10.1111/bcp.12041
- By:
- Publication type:
- Article
Palliative Care Issues for Transfusion-Dependent Patients #359.
- Published in:
- Journal of Palliative Medicine, 2018, v. 21, n. 9, p. 1359, doi. 10.1089/jpm.2018.0347
- By:
- Publication type:
- Article
Update in Hematology and Medical Oncology: Evidence Published in 2011.
- Published in:
- Annals of Internal Medicine, 2012, v. 157, n. 4, p. 276, doi. 10.7326/0003-4819-156-7-201204030-00415
- By:
- Publication type:
- Article
PBS listing for Revlimid.
- Published in:
- 2013
- Publication type:
- Product Review
Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 4, p. 663, doi. 10.1007/s00277-014-2259-x
- By:
- Publication type:
- Article
Concurrent administration of darbepoetin alfa, cyclosporine A, and prednisolone is useful for T cell large granular lymphocyte leukemia associated with myelodysplastic syndrome complicated by Coombs-negative hemolytic anemia.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Transient and fully reversible leukocytosis in a myelodysplastic syndrome patient upon initiation of azacitidine treatment.
- Published in:
- 2013
- By:
- Publication type:
- Letter
A case of late onset erythropoietic protoporphyria associated with myelodysplastic syndrome treated by the combination of beta carotene and azacitidine.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1325, doi. 10.1007/s00277-013-1772-7
- By:
- Publication type:
- Article
Comparison of 7-day azacitidine and 5-day decitabine for treating myelodysplastic syndrome.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 7, p. 889, doi. 10.1007/s00277-013-1702-8
- By:
- Publication type:
- Article
High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 5, p. 621, doi. 10.1007/s00277-013-1686-4
- By:
- Publication type:
- Article